文献
J-GLOBAL ID:201702240335193259
整理番号:17A1437547
個別化医療臨床サービスにより評価された患者における標的体細胞変異の定量:適応外薬物使用のための考察【Powered by NICT】
Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use
著者 (6件):
Vela Cory M.
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
Knepper Todd C.
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
Gillis Nancy K.
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
Walko Christine M.
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
McLeod Howard L.
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
Hicks J. Kevin
(Division of Population Science, DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
資料名:
Pharmacotherapy
(Pharmacotherapy)
巻:
37
号:
9
ページ:
1043-1051
発行年:
2017年
JST資料番号:
D0007B
ISSN:
0277-0008
CODEN:
PHPYDQ
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)